News

Tavapadon as adjunct to levodopa increases daily ON time in Parkinson's disease
For patients with Parkinson's disease with motor fluctuations, the oral once-daily, selective D1/D5 partial dopamine agonist ...
HealthDay on MSN13h
AAN: Tavapadon as Adjunct to Levodopa Ups Daily ON Time in Parkinson Disease
For patients with Parkinson disease with motor fluctuations, the oral once-daily, selective D1/D5 partial dopamine agonist ...
Doctors didn't warn women of 'risky sex' drug urges
Prevalence rates of what GSK calls "deviant" sexual behaviours caused by the drugs are unknown and tend to be under-reported ...
European Medical Journal6h
Parkinson’s Symptoms Improved in TEMPO-2 Trial: AAN 2025
The Phase 3 TEMPO-2 trial presented at AAN 2025 reported that tavapadon significantly improved motor symptoms and daily ...
IGC Pharma announces interim data from Phase 2 trial of IGC-AD1
IGC Pharma (IGC) announced additional interim results from its ongoing Phase 2 clinical trial on IGC-AD1, an investigational treatment for ...